Skip to main content
Matricelf Ltd. logo

Matricelf Ltd. — Investor Relations & Filings

Ticker · MTLF ISIN · IL0011767915 TA Professional, scientific and technical activities
Open in API
Filings indexed 12 across all filing types
Latest filing 2026-01-28 Investor Presentation
Country IL Israel
Listing TA MTLF

About Matricelf Ltd.

https://matricelf.com/

Matricelf Ltd. is a preclinical-stage biotechnology company specializing in regenerative medicine and tissue engineering. The company develops a proprietary platform for creating fully autologous, patient-specific tissue implants. This technology combines a patient's induced Pluripotent Stem Cells (iPSCs) with a personalized, thermo-responsive hydrogel derived from their own extracellular matrix (ECM). The iPSCs are differentiated within this hydrogel to generate functional tissue. This autologous approach is designed to minimize the risk of immune rejection and provide a personalized, curative therapy. Matricelf's primary focus is on developing a one-time treatment for spinal cord injuries, aiming to bridge damaged tissue and restore lost function. The platform is also being explored for other conditions, including stroke, traumatic brain injury, and myocardial infarction.

Recent filings

Filing Released Lang Actions
INVESTORS PRESENTATION
Investor Presentation Classification · 1% confidence The document is a slide deck presentation titled 'Matricelf' that outlines the company's technology, clinical trial progress, market opportunity, and management team. It contains forward-looking statements, scientific data, and strategic roadmaps typical of an investor presentation. It is not a formal financial report (10-K/IR), nor is it a short announcement (RPA/RNS). It fits the definition of an Investor Presentation (IP) perfectly.
2026-01-28 English
INVESTORS PRESENTATION
AGM Information Classification · 1% confidence The document is a short regulatory filing (T121) from the Israel Securities Authority (ISA) system (MAGNA). It serves as a cover page for an attached file titled 'Company Presentation January 2026'. According to the 'Menu vs Meal' rule, since the document is a brief notification announcing the publication of an attached presentation rather than the presentation itself, it is classified as a Report Publication Announcement (RPA).
2026-01-28 Russian
COMPANY'S PRESENTATION
Investor Presentation Classification · 1% confidence The document is a multi-page presentation containing slides with titles like 'REGENERATING THE FUTURE OF PERSONALIZED MEDICINE', 'Vision', 'Mission', 'Matricelf: Overview', 'Milestones to date', 'Competitive advantage', 'Product NewRalTM', 'Market Size & Business Model', 'Financing', and lists of management and scientific advisors. It heavily features forward-looking statements, proprietary technology descriptions (Autologous 3D Tissue Engineering, Spinal Cord Injury treatment), and financial/milestone targets (e.g., 'Next milestone: IND enabling pre-clinical data – H2/2025', 'Seeking for $7m'). This structure and content strongly indicate an Investor Presentation designed to showcase the company's strategy, technology, and financial needs to potential investors. This aligns perfectly with the definition for Investor Presentation (IP).
2024-09-08 Hebrew (modern)
COMPANY'S PRESENTATION
AGM Information Classification · 1% confidence The document text contains Hebrew characters and appears to be a formal announcement or filing related to a company named 'MATRICELF LTD'. Key indicators include dates (08/09/2024), references to regulatory bodies (www.isa.gov.il, suggesting the Israel Securities Authority), and mentions of a meeting scheduled via Microsoft Teams. The text also references a PDF file ('isa.pdf') and mentions a 'PPT' file in the filename, suggesting presentation materials or an announcement related to a meeting. The structure and content strongly suggest an announcement regarding a shareholder meeting or corporate event, rather than a full financial report (10-K, IR) or a simple earnings release (ER). Given the context of a scheduled event and the reference to a presentation file, this is most likely related to the Annual General Meeting (AGM) or materials distributed for it. Since the document is short and seems to be an announcement/notice rather than the full presentation itself, AGM-R (AGM Information) is the most appropriate classification, assuming the linked material is the AGM presentation/materials.
2024-09-08 Russian
INVESTORS PRESENTATION
Investor Presentation Classification · 1% confidence The document is a detailed presentation titled 'REGENERATING THE FUTURE OF MEDICINE' by Matricelf Ltd. It covers the company's vision, platform technologies (tissue engineering, 3D bioprinting), first product in development (neural tissue for spinal cord injury), market size, roadmap to clinical trials, competitive landscape, management team, and scientific advisory board. This structure is characteristic of an Investor Presentation (IP), designed to inform potential and current investors about the company's strategy, technology, and financial outlook, rather than being a formal regulatory filing like a 10-K or an earnings release (ER). Since the document is substantial (over 11,000 characters) and comprehensive, it is classified as an Investor Presentation.
2024-03-27 English
INVESTORS PRESENTATION
AGM Information Classification · 1% confidence The document text contains Hebrew characters and appears to be a formal announcement or filing related to 'MATRICELF LTD'. Key phrases include '���� ������: ***���� ������� 2024***' (which translates roughly to 'Document Title: ***Annual Report 2024***' or similar high-level report title, although the exact translation is difficult without full context, the structure suggests a formal report announcement) and references to dates (27/03/2024) and regulatory bodies (www.isa.gov.il, www.tase.co.il). Crucially, the document is very short (2478 characters) and contains placeholders/links/references to an attached file ('*1711477727_240326_Matricelf_2024_PPT_Final_PDF_isa.pdf*') and mentions the publication date/time. This strongly suggests it is an announcement *about* a report rather than the report itself. Given the title structure suggesting an annual document ('2024') and the nature of the announcement, it is likely related to the Annual Report (10-K) or a general regulatory filing. However, because it is an announcement of publication rather than the full content, the 'Report Publication Announcement' (RPA) category is the most appropriate fit based on Rule 2 (The 'MENU VS MEAL' Rule). If the content were the full 10-K, it would be classified as 10-K, but this is clearly a cover/announcement page.
2024-03-27 Russian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.